22nd September 2021 | Pharma Updates
Schott invests 70 mn EUR in its Gujarat facility
Schott has invested 70 million EUR in its glass tubing site in Gujarat.
JPDA raises concern over pharma drugs
Jammu Pharmaceutical Distributors Association (JPDA) charged drug organizations with corrupt practices.
Impending Drug city in Hyderabad will be exporter-friendly: Official
Principal Secretary Jayesh Ranjan says that the pharma city in Hyderabad will provide the complete infrastructure required by exporters.
Lincoln earmarks Rs 30 crore for the expansion of Cephalosporin
The drug company plans to make 20 or more Cephalosporin products including clavulanate tablets, cefalexin oral suspension BP, cefixime capsules, and so forth.
Bulk drugs Small and Medium Enterprises raise a concern about Centre giving just 11% share to MSMEs in 2nd PLI scheme
The Union Cabinet approved the second PLI second scheme in June 2021 to help the Indian pharma sector for financial years 2020-21 to 2028-29.
Roche’s antibody mixture gets CDSCO approval
Central Drug Standard Organization has given nod to Roche’s imdevimab and casirivimab for use in post-exposure of prophylaxis of Covid for people above 18 years of age.
Macleods Pharma Ltd. Picks Banks for USD 1 bn Mumbai IPO
Macleods Pharma has chosen banks including ICICI Securities Ltd. and Edelweiss Financial Services Ltd. to manage its Mumbai IPO.